JPRN-UMIN000020658已完成未知
Study on the effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms due to benign prostatic hyperplasia - Effect of tadalafil on bladder blood flow in benign prostatic hyperplasia
Hidehiro Kakizaki0 个研究点目标入组 22 人开始时间: 2016年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 75years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •postvoid residual urine 150 ml or more, uncontrolled diabetes mellitus, patients taking medication for lower urinary tract symptoms, patients who underwent surgery or radiation to the prostate
研究者
相似试验
已完成
不适用
Effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms secondary to benign prostate hyperplasiabenign prostate hyperplasiaJPRN-UMIN000016034Department of Urology, Kyorin University School of Medicine50
尚未招募
不适用
Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancerProstate cancerJPRN-UMIN000047981ara Medical University220
进行中（未招募）
1 期
Effects of single dose tadalafil on sphincter function in healthy femalesrinary stress incontinence and fecal incontinenceMedDRA version: 22.0Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2020-005839-76-DKniversity hospital Bispebjerg and Frederiksberg, Department of Clinical Pharmacology24
尚未招募
不适用
The role of tadalafil for lower urinary tract symptoms after brachytherapyProstatic cancerJPRN-UMIN000015767Department of Urology, Shinshu University Hospital200
已完成
3 期
The assessment of effect of Tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasiaBenighn Prostatic Hypertrophia.Benign Prostatic HypertrophiaIRCT201008094541N1Guilan University of Medical Sciences132